Cerevance Companies
Cerevance is a neuroscience-focused company developing therapies for brain diseases associated with aging. Using their proprietary NETSseq technology, they identify targets to treat cognitive decline and neurodegenerative disorders.
Investors
Industry:
Biotechnology, Heath and Wellness Technology
Estimated Revenue:
$100M to $500M
Headquarters:
the United States, The United StatesCerevance
Founded Date:
2016